PhD, Mathematics, Applied (Operations Research)
MSc, Mathematics, Applied
University of Maryland at College Park, College Park, MD
Davidson College, Davidson, NC
Will Herring, PhD, is an Executive Director in the Health Economics group at RTI-HS and provides a strong interest and extensive background in mathematical modeling and decision analysis across the healthcare system. Over more than a decade with RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his research been used to inform strategic decisions during the development of new health technologies and to support submissions to healthcare payers and regulatory agencies. Most recently, his research has focused on economic modeling for chronic progressive diseases (Alzheimer’s disease [AD], multiple sclerosis, and nonalcoholic steatohepatitis) and for conditions and interventions affecting older adults (AD, herpes zoster vaccination, and respiratory syncytial virus vaccination). Dr. Herring has presented his research on economic modeling and value assessment challenges for AD in multiple national and international settings and is a member of the steering committee for the International Pharmaco-Economic Collaboration for Alzheimer’s Disease (IPECAD) Modelling Group. His experience extends to a range of other therapeutic areas, including ophthalmology (diabetic retinopathy and age-related macular degeneration), respiratory (asthma and chronic obstructive pulmonary disease), dermatology (atopic dermatitis and psoriasis), diabetes, chronic hepatitis C, and oncology. He is Affiliated to Research at the Karolinska Institutet and is a member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the ISPOR Open-Source Modeling Special Interest Group. His research has been published in peer-reviewed journals, including PharmacoEconomics, Journal of Managed Care and Specialty Pharmacy, Neurology and Therapy, and Vaccine.